Finance Director - MRL Composition of Matter and R&D Capital Finance at Merck
Allentown, Pennsylvania Area
Finance Director - Global CapEx
March 2014 to November 2019
Whitehouse Station, New Jersey
Finance Director - MRL Composition of Matter and R&D Capital Finance
West Point, PA
Finance Director / Regional Controller - North America Pharmaceutical & Consumer Care Manufacturing
December 2012 to March 2014
Whitehouse Station, NJ
Associate Finance Director - Biologics Sourcing & Product Lifecycle
April 2011 to December 2012
West Point, PA
Finance Manager - Merck Mfg Division - HQ Central Services
February 2008 to March 2011
Finance Manager - Merck Mfg Division Center of Excellence
May 2007 to February 2008
Johnson & Johnson
Sr. Financial Analyst - Cordis Neurovascular Sales & Marketing
April 2006 to April 2007
Sr. Financial Analyst
June 2004 to March 2006
Sr. Internal Auditor
July 2002 to June 2004
Finance Director - Global CapEx @ Merck Responsible for the reporting and forecasting of Merck's worldwide capital spending (2013 spend = $1.5 Billion) From March 2014 to November 2019 (5 years 9 months) Whitehouse Station, New JerseyFinance Director - MRL Composition of Matter and R&D Capital Finance @ Merck West Point, PAFinance Director / Regional Controller - North America Pharmaceutical & Consumer Care Manufacturing @ Merck • Responsible for the development of budgets, forecasts, long range plans, inventory & capital reporting for all pharmaceutical and consumer care manufacturing plants in North America (gross spend of ~$1B), and for my first 3 months, Latin America• Oversaw a ’14 budget that delivered 10% labor & overhead standard cost productivity• Developed a clear, highly collaborative budget COGS review process with Consumer Care (MCC) Finance to ensure transparency and integrity in the MCC-specific productivity handoff.• Lead a total team of ~20 professionals, spanning the US, Puerto Rico and Canada From December 2012 to March 2014 (1 year 4 months) Whitehouse Station, NJAssociate Finance Director - Biologics Sourcing & Product Lifecycle @ Merck • Oversaw the development of the annual budget, quarterly forecasts (total consolidated budget = $165MM) for the Biologics Commercialization area, which focuses on bringing product mfg processes from the lab scale to commercial production scale; analyze financial variances & performance trends and communicate issues to the VP, Biologics Mfg and Exec Director, BMSC.• Provide financial & economic analysis to support strategic decisions for Merck’s biologics programs, including production siting analysis (i.e. make vs buy), capital expenditures, market entrance strategies and cost reduction initiatives• Regularly collaborate with and influence colleagues from multiple areas including Supply Chain Management, Procurement, Marketing, and Tax to deliver beneficial recommendations to Merck Sr. Leadership• Serve as the primary Merck financial liaison for a key contract manufacturing relationship • Lead and develop a staff of 1 Sr. Financial Analyst From April 2011 to December 2012 (1 year 9 months) West Point, PAFinance Manager - Merck Mfg Division - HQ Central Services @ Merck · Oversaw the development of the MMD annual budget, quarterly forecasts (total consolidated budget = $10B, having $2B direct P&L impact); analyze financial variances & performance trends and communicate divisional issues to the President, Merck Manufacturing and his direct reports.· Established process and tools required for the MMD 5-yr long range operating plan. Process focused on major business initiatives/drivers and can easily be scaled to incorporate more or less level of detail as needed· Managed the annual budgeting and quarterly forecasting for MMD’s Restructuring program; reviewed performance & variances with Corporate Finance management & external auditors, processed quarterly accelerated depreciation for assets totaling over $200MM across multiple sites· Created method to calculate manufacturing variances requiring capitalization on a global basis (impacting over 20+ sites); established variance tracking & control mechanism to ensure balance sheet accuracy and support non-current inventory reporting· Served as primary point of contact with Corporate and other Merck divisions; addressed ad-hoc requests regarding audit, statutory & management financial reporting and other business needs· Temporarily assumed responsibility for the MMD HQ Finance team as a result of an unexpected 4-month medical leave for the Director, MMD HQ Finance, leading a team of 2 analysts From February 2008 to March 2011 (3 years 2 months) Finance Manager - Merck Mfg Division Center of Excellence @ Merck · Implemented standard financial reporting processes & procedures for the Merck Manufacturing Division· Provided regional financial support to the North American & Latin American plants (~15 sites) for the annual budget and quarterly forecasts; prepared performance summaries and variance analyses for the Senior VP, North & Latin American Operations· Coordinated the worldwide 2008 budgeting cycle for the Merck Manufacturing Division, including the establishment of universal calendars, templates, guidance communications· Supervised staff of 3 analysts From May 2007 to February 2008 (10 months) Sr. Financial Analyst - Cordis Neurovascular Sales & Marketing @ Johnson & Johnson · Prepared the annual budgets and numerous scenario analyses for the Cordis Neurovascular US Sales & WW Marketing groups: ~$20MM in spending.· Performed budget variance analyses to understand drivers of spending change· Analyzed price-volume mix impact on sales performance, as well as royalties, sales force commissions, product pricing for potential contracts and sales reserves· Simplified methodology for managing co-promotion activities with another Cordis franchise while providing adequate commissions to sales force· Automated headcount reporting tools using Excel macros. From April 2006 to April 2007 (1 year 1 month) Sr. Financial Analyst @ Merck · Prepared the annual budgets for the West Point Quality Organization (WPQO) and Vaccine Tech & Engineering group (VTE): ~$100MM in combined spending.· Revised monthly financial forecasts based on changes in business drivers, performed variance analysis & presented financial performance metrics to WPQO and VTE Vice-Presidents and their direct reports monthly.· Implemented new Excel-based models to streamline the monthly forecast and annual budget data collection process. · Developed an Excel-based headcount reporting model for the WPQO to simplify efforts to meet corporate requirements.· Financial liaison for Six Sigma project team to determine lab supply efficiencies.· Served on Finance Recruiting teams to identify talent at the 2004 and 2005 National Black MBA Conferences From June 2004 to March 2006 (1 year 10 months) Sr. Internal Auditor @ Merck · Evaluated the adequacy and effectiveness of Merck’s internal control environment through identifying significant business risks and conducting detailed testing of critical business processes.· Supervised audit teams during 3-week fieldwork engagements, and prepared written reports of audit findings and recommendations for senior management. Completed 11 audit assignments as the Auditor-in-Charge.· Recognized and shared best practices for improvement throughout Merck’s worldwide operations.· Participated in audits of international subsidiaries, divisional entities, corporate, and third parties.· Developed audit recommendations and implementation plans in collaboration with entity management teams and Client Audit Directors in order to mitigate potential risks.· Worked with domestic departments and international subsidiaries to enhance their internal control documentation to assure Sarbanes-Oxley compliance. From July 2002 to June 2004 (2 years)
What company does Christopher Forbes work for?
Christopher Forbes works for Merck
What is Christopher Forbes's role at Merck?
Christopher Forbes is Finance Director - Global CapEx
What industry does Christopher Forbes work in?
Christopher Forbes works in the Pharmaceuticals industry.
Extraversion (E), Intuition (N), Feeling (F), Judging (J)
2 year(s), 2 month(s)
There's 72% chance that Christopher Forbes is seeking for new opportunities
Enjoy unlimited access and discover candidates outside of LinkedIn
One billion email addresses and counting
Everything you need to engage with more prospects.
ContactOut is used by
76% of Fortune 500 companies